COPENHAGEN, Denmark, Oct. 9, 2024 /PRNewswire/ — Antag Therapeutics, a leading biopharmaceutical company focused on targeting the Glucose-Dependent Insulinotropic Polypeptide (GIP) receptor to pioneer novel treatments for obesity, today announced that the U.S. Food and […]
Tag: Clinical Trials & Medical Discoveries
Sciwind Biosciences Announces Oral Presentation on Oral GLP-2 Research Progress at the 32nd United European Gastroenterology Week (UEG Week 2024)
BEIJING and HANGZHOU, China, Oct. 7, 2024 /PRNewswire/ — The 32nd United European Gastroenterology Week (UEG Week 2024) will take place in Vienna, Austria, from October 12 to 15, 2024. UEG Week is the largest gastroenterology […]
Darling Ingredients Introduces Nextida™ GC
Next Generation Collagen Peptide that Targets Post-Meal Glucose Spike IRVING, Texas, Oct. 7, 2024 /PRNewswire/ — Darling Ingredients Inc. (NYSE: DAR) today announced that it has launched Nextida™ GC, a new collagen peptide that displayed […]
Hansa Biopharma’s HNSA-5487 Achieved Rapid and Highly Robust IgG Reduction by More Than 95% and Clear Redosing Potential in First-in-Human Trial
LUND, Sweden, Oct. 7, 2024 /PRNewswire/ — Hansa Biopharma AB, (“Hansa” or the “Company”) (NASDAQ STOCKHOLM: HNSA), today announced positive results from a 12-month follow up analysis from the NICE-01 trial of HNSA-5487, the Company’s next […]
Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024
– New proteomic analyses show that rezpegaldesleukin increases the protein levels of immune-regulating pathways while reducing specific serum proteins known to be elevated in patients with atopic dermatitis – SAN FRANCISCO, Sept. 25, 2024 /PRNewswire/ […]